As expected, knockdown of XIST decreased the protein levels of Wnt1, β-catenin and cyclin-D1 in bladder cancer cells, while down-regulation of miR-139-5p could restore this repression (Figure 7A). Here, XIST is linked to urinary bladder carcinoma.